Published in Naunyn Schmiedebergs Arch Exp Pathol Pharmakol on January 01, 1969
Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD) Clin Exp Immunol (1995) 4.81
Flavonoids and related compounds as inhibition of arachidonic acid peroxidation. Prostaglandins (1980) 1.17
[Brain carbohydrate metabolism following blockade of the pentose phosphate pathway by 6-aminonicotinamide]. Hoppe Seylers Z Physiol Chem (1970) 1.03
Brain disorders induced by pharmacological blockade of the pentose phosphate pathway. Biochem Biophys Res Commun (1969) 1.03
Nontoxic and toxic oligopeptides with D-amino acids and unusual residues in Microcystis aeruginosa PCC 7806. Arch Microbiol (1989) 1.02
Association of T102C polymorphism of the 5-HT2A receptor gene with psychiatric status in fibromyalgia syndrome. Rheumatol Int (2001) 0.98
Significance of the catechol-O-methyltransferase gene polymorphism in migraine. Brain Res Mol Brain Res (2001) 0.98
Serum IL-1beta, sIL-2R, IL-6, IL-8 and TNF-alpha in schizophrenic patients, relation with symptomatology and responsiveness to risperidone treatment. Mediators Inflamm (2001) 0.98
The circular dichroism of ribosomal ribonucleic acids. Biochem J (1976) 0.97
An apparently dominant bipolar affective disorder (BPAD) locus on chromosome 20p11.2-q11.2 in a large Turkish pedigree. Eur J Hum Genet (2001) 0.96
Interactions of sulfhydryl agents and soybean lipoxygenase inhibitors. Biochem Pharmacol (1981) 0.95
Significance of serotonin transporter gene polymorphism in migraine. J Neurol Sci (2001) 0.91
Association of the T102C polymorphism of 5-HT2A receptor gene with aura in migraine. J Neurol Sci (2001) 0.87
Preparation of human and murine monoclonal antibodies: antigens combined with or conjugated to lipopeptides constitute potent immunogens for in vitro and in vivo immunizations. Hum Antibodies Hybridomas (1990) 0.87
T102C polymorphism of the 5-HT2A receptor gene may be associated with temporomandibular dysfunction. Oral Dis (2004) 0.86
Red blood cell nitric oxide levels in patients with schizophrenia. Schizophr Res (2001) 0.86
Oxidation of polyunsaturated fatty acids and lipids through thiyl and sulfonyl radicals: reaction kinetics, and influence of oxygen and structure of thiyl radicals. Arch Biochem Biophys (1992) 0.85
[Experimental myelopathy--biochemical basis of its cellular pathogenesis (author's transl)]. Klin Wochenschr (1973) 0.82
Molecular characterization of a phosphatidylcholine-hydrolyzing phospholipase C. Eur J Biochem (2001) 0.82
Thiyl radical attack on polyunsaturated fatty acids: a possible route to lipid peroxidation. Biochem Biophys Res Commun (1989) 0.81
Tetrahydrobiopterin and total biopterin content of neuroblastoma (N1E-115, N2A) and pheochromocytoma (PC-12) clones and the dependence of catecholamine synthesis on tetrahydrobiopterin concentration in PC-12 cells. J Neurochem (1984) 0.79
[Biosynthesis of the basement membrane. Utilization of proline and glucose for the formation of components of the glomerular basement membrane in vitro]. Naunyn Schmiedebergs Arch Pharmakol (1971) 0.79
Determination of reduced biopterins by high pressure liquid chromatography and subsequent electrochemical detection. Hoppe Seylers Z Physiol Chem (1982) 0.79
[Effect of 6-aminonicotinic acid amide on insulin dependant glucose uptake in epididymal fat tissue]. Naunyn Schmiedebergs Arch Pharmakol Exp Pathol (1966) 0.79
[Extraction and morphological characterization of a basement membrane fraction from the renal cortex in the rat]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1965) 0.78
[Morphological and chemical formation of isolated basal membranes of the rat renal cortex]. Histochemie (1967) 0.78
[The effect of 6-aminonicotinamide on the distribution of sodium and potassium ions between the extracellular and intracellular space in the liver and skeletal muscles]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1966) 0.78
[Prostaglandin synthetase inhibition by flavonoids and phenolic compounds in relation to their O2--scavenging properties (author's transl)]. Arch Pharm (Weinheim) (1980) 0.78
Uptake, production and metabolism of cysteinyl leukotrienes in the isolated perfused rat liver. Inhibition of leukotriene uptake by cyclosporine. Biochem J (1989) 0.78
Is the dopamine D3 receptor mRNA on blood lymphocytes help to for identification and subtyping of schizophrenia? Mol Biol Rep (2010) 0.78
Blocking of pentose phosphate pathway in the brain of rats by 6-aminonicotinamide. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1969) 0.78
Regeneration of renal tubular cells after lesion by temporary ischaemia, folic acid, and 2,4,5-triamino 6-styrylpyrimidine. Naunyn Schmiedebergs Arch Pharmakol (1970) 0.78
[The effect of antimetabolites on cell metabolism in warm-blooded animals]. Internist (Berl) (1966) 0.78
The sensitized liver represents a rich source of endogenous leukotrienes. Hepatology (1991) 0.78
Dual inhibitory activities of tannins from Hamamelis virginiana and related polyphenols on 5-lipoxygenase and lyso-PAF: acetyl-CoA acetyltransferase. Planta Med (1997) 0.77
[Effect of aescin on glucose transport in adipose tissue and ascites tumor cells]. Naunyn Schmiedebergs Arch Pharmakol (1971) 0.77
Ribonucleotides during the regeneration of the rat kidney after lesions by folic acid, HgCl2 and ligation of the ureter. Naunyn Schmiedebergs Arch Pharmacol (1974) 0.77
In vitro inhibition and stimulation of purified prostaglandin endoperoxide synthase by flavonoids: structure-activity relationship. Pharmacology (1992) 0.76
Dopa-release from mouse neuroblastoma clone N 1 E-115 into the culture medium. A test for tyrosine hydroxylase activity. Naunyn Schmiedebergs Arch Pharmacol (1982) 0.76
PC12 cells: a model system for studying drug effects on dopamine synthesis and release. Arch Int Pharmacodyn Ther (1987) 0.76
[Mechanisms of pharmacologic interventions in vital functions of the cell]. Arch Klin Exp Ohren Nasen Kehlkopfheilkd (1967) 0.75
Behaviour of the glycolytic system of rat brain and kidney in vivo after in hibition of the glucosephosphate isomerase. II. Substrate concentrations under the influence of ischemia, 6-aminonicotinamide, and 2-deoxyglucose. Hoppe Seylers Z Physiol Chem (1972) 0.75
The peptide toxin of the cyanobacterium Microcystis aeruginosa PCC 7941. Isolation and analysis by nuclear magnetic resonance and fast atom bombardment mass spectroscopy. J Chromatogr (1988) 0.75
[The impairment of glycogen metabolism in adipose tissue by 6-aminonicotinamide as influenced by the inhibition of phosphofructokinase]. Naunyn Schmiedebergs Arch Pharmacol (1972) 0.75
[Nerve cell clonal lines in culture--models for studying the molecular basis of neuropharmacological actions]. Klin Wochenschr (1983) 0.75
Platelet aggregation inhibiting and anticoagulant effects of oligoamines, XXV: Interactions of the oligoamine RE 1492 with biomembranes. Arch Pharm (Weinheim) (1995) 0.75
[Localization of natriuretic action of 6-aminonicotinamide in rat kidney]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1968) 0.75
Isolation and characterization of internalized glioma cell membranes. Cell Tissue Res (1984) 0.75
Cholecystokinin in human stomach. Immunohistochemical investigations on the distribution and the effects on gastric motility in vitro. Ann N Y Acad Sci (1994) 0.75
Relationship between the DAT1 gene and the effects of methylphenidate administration in adult attention deficit hyperactivity disorder: a magnetic resonance spectroscopy study. Eur Rev Med Pharmacol Sci (2016) 0.75
[Studies on the effect of 6-aminonicotinamide on the glucose metabolism of fat tissue]. Naunyn Schmiedebergs Arch Pharmakol (1969) 0.75
[Biosynthesis of a pteridine-containing nucleotide in the kidney after administration of triamterene]. Klin Wochenschr (1965) 0.75
[Drug safety, toxicology and incompatibility of various concurrently administered drugs]. Dtsch Krankenpflegez (1974) 0.75
[Evaluation of the therapeutic value of drugs--a responsibility of clinical pharmacology]. Internist (Berl) (1986) 0.75
[Effects of N-amidino-3,5-diamino-6-chloro-pyrazinecarboxamide (amiloride) on transport processes and metabolic capacities of adipose tissue]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1968) 0.75
[The nature of the cytoplasmic red fluorescence in acridine orange fluorescent neuroblastoma cells]. Bibl Anat (1981) 0.75
Substrates for arachidonic acid co-oxidation with peroxidase/hydrogen peroxide. Further evidence for radical intermediates. Biochem Pharmacol (1989) 0.75
[Changes in electrolyte movements induced by diuretics in isolated adipose tissue]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1968) 0.75
Apomorphine does not decrease tissue levels of tetrahydrobiopterin in vivo. Eur J Pharmacol (1986) 0.75
[Effects of amiloride and triamterene on lipolysis and enzyme-induced glucose transport in isolated fat cells]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1969) 0.75
Decreasing inhibitory potency of prostaglandin synthetase inhibitors during their cooxidative metabolism. Studies on aminophenols, pyrazolon derivatives and 1,3-diphenylisobenzofuran. Pharmacology (1983) 0.75
Inhibition of prostaglandin synthetases derived from neuronal and glial cells and rat renal medulla by ortho-, meta- and para-substituted aminophenolic compounds. Prostaglandins Leukot Med (1983) 0.75
Action of lisuride on reserpine-induced muscular rigidity in rats after local application into the striatum, ventricular space or the spinal subarachnoid space. Arzneimittelforschung (1982) 0.75
Inhibition of biopterin synthesis and DOPA production in PC-12 pheochromocytoma cells induced by 6-aminonicotinamide. Naunyn Schmiedebergs Arch Pharmacol (1989) 0.75
[Pharmacologic studies on the problem of the selective vulnerability of the brain]. Arzneimittelforschung (1965) 0.75
Ventral free oral mucous membrane graft for bulbar urethral stricture. Mymensingh Med J (2012) 0.75
[Important practical principles of pharmacokinetics]. Internist (Berl) (1982) 0.75
Mouse neuroblastoma clone N1E-115: a suitable model for studying the action of dopamine agonists of tyrosine hydroxylase activity. Biochem Pharmacol (1982) 0.75
Some metabolic and morphological alterations in Yoshida ascites tumour cells caused by 6-aminonicotinamide. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol (1972) 0.75
[Effect of triamterene on insulin stimulable processes in adipose tissue]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1967) 0.75
[Introduction]. Internist (Berl) (1966) 0.75
Functional disorders of the brain induced by synthesis of nucleotides containing 3-acetylpyridine. Z Klin Chem Klin Biochem (1968) 0.75
Phagocytosis and morphological development of rat astrocytes in primary cultures. Cell Mol Biol (1982) 0.75
[Fundamentals and development of drug research, Karlsruhe, August 31, 1964]. Pharmakotherapia (1965) 0.75
Effects of methylphenidate treatment on the cerebellum in adult attention-deficit hyperactivity disorder: a magnetic resonance spectroscopy study. Eur Rev Med Pharmacol Sci (2017) 0.75
Metabolic alterations in Yoshida ascites tumour cells caused by 6-aminonicotinamide and prevented by nicotinamide. Naunyn Schmiedebergs Arch Pharmacol (1972) 0.75
In vitro deacetylation studies of acetamidophenolic compounds in rat brain, liver and kidney. Arzneimittelforschung (1984) 0.75
Endogenous leukotriene production elicited by antigen challenge of sensitized livers. Adv Prostaglandin Thromboxane Leukot Res (1991) 0.75
[Use of O-nitrophenylbutyrate as source of error in the measurement of the 2-PAM reactivity potential of alkylphosphate-poisoned serum cholinesterase]. Z Klin Chem Klin Biochem (1968) 0.75
[Sleeping pill misuse and its prevention]. Nervenarzt (1968) 0.75
[Structure and function of the kidney glomerulus in experimental nephrosis]. Nihon Ishikai Zasshi (1966) 0.75
Evaluation of neurotropic drug actions on tyrosine hydroxylase activity and dopamine metabolism in clonal cell lines. Arzneimittelforschung (1985) 0.75
(+)-Cyanidanol-3 as inhibitor of prostaglandin synthetase. Studies on renal medulla and liver of the rat in vitro and in vivo. Naunyn Schmiedebergs Arch Pharmacol (1979) 0.75
[Mechanisms of pharmacologic intervention in the vital functions of the cell]. Arch Klin Exp Ohren Nasen Kehlkopfheilkd (1967) 0.75
Proceedings: Influence of calcium ions and aescin on transport processes in Yoshida ascites tumor cells. Naunyn Schmiedebergs Arch Pharmacol (1975) 0.75
[Aescin in adipose tissue and ascites tumor cells]. Naunyn Schmiedebergs Arch Pharmakol (1970) 0.75
[Treatment of chronic low serum potassium levels in potassium losing kidney by amiloride (author's transl)]. Med Klin (1974) 0.75
[On the size of the pore equivalent in isolated basement membrane of the rat kidney]. Pflugers Arch Gesamte Physiol Menschen Tiere (1966) 0.75
[Traumatic myocardial infarct during a soccer game. Clinical course study including coronarography]. Z Kardiol (1973) 0.75
[Vital acridine orange fluorescence of various differentiation phases of neuroblastoma cells in vitro]. Bibl Anat (1981) 0.75
Citalopram-induced photopigmentation. J Dermatol (2001) 0.75
Biosynthesis and action of dinucleotides containing 6-aminonicotinamide on membrane transport processes. Arzneimittelforschung (1968) 0.75
Production and immunohistochemical characterization of monoclonal antibodies directed against renal basement membranes of rats. Histol Histopathol (1988) 0.75
Relationship between the SNAP-25 gene and the effects of methylphenidate on the anterior cingulate cortex of patients with adult attention deficit hyperactivity disorder: a magnetic resonance spectroscopy study. Eur Rev Med Pharmacol Sci (2016) 0.75
Vitamin E or probucol as donors for oxidation of human low-density lipoprotein by peroxidases/H2O2. Pharmacology (1994) 0.75
A structure-activity study on the influence of phenolic compounds and bioflavonoids on rat renal prostaglandin synthetase. Naunyn Schmiedebergs Arch Pharmacol (1979) 0.75
Effect of apomorphine, alpha-methylparatyrosine, haloperidol and reserpine on DOPA production in clonal cell lines (PC-12 and N1E-115). Biochem Pharmacol (1985) 0.75